Enovis Corp (ENOV) Operating Margin
- Operating margin · 12 months: Value -45.14%; Formula and calculation Operating income / revenue. Period ending 2026-07-03..
Operating margin
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -45.14% | Operating income / revenue. Period ending 2026-07-03. $-1.04B ÷ $2.30B × 100 ≈ -45.14% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -1.04B USD | Operating Income (Loss) |
| Revenue | 2.30B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 893.53M USD | Cost of Goods and Services Sold |
| Research and development | 124.32M USD | Research and Development Expense |
| Selling, general and administration | 1.08B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-03 | $-1.04B | $2.30B | $893.53M | $124.32M | $1.08B | -45.14% |
| 2026-04-03 | $-1.07B | $2.28B | $899.85M | $123.34M | $1.08B | -47.00% |
| 2025-12-31 | $-1.12B | $2.25B | $902.79M | $120.33M | $1.07B | -50.01% |
| 2025-10-03 | $-1.29B | $2.23B | $929.91M | $112.92M | $1.06B | -57.62% |
| 2025-07-04 | $-760.05M | $2.19B | $928.67M | $103.67M | $1.04B | -34.71% |
| 2025-04-04 | $-787.47M | $2.15B | $935.10M | $96.45M | $1.04B | -36.62% |
| 2024-12-31 | $-775.72M | $2.11B | $926.87M | $91.30M | $1.03B | -36.81% |
| 2024-09-27 | $-116.72M | $2.00B | $864.04M | $85.67M | $980.66M | -5.83% |
| 2024-06-28 | $-105.48M | $1.91B | $819.84M | $85.08M | $935.05M | -5.51% |
| 2024-03-29 | $-75.75M | $1.82B | $763.70M | $80.52M | $878.83M | -4.17% |
| 2023-12-31 | $-65.71M | $1.71B | $716.42M | $75.33M | $830.30M | -3.85% |
| 2023-09-29 | $-88.14M | $1.66B | $702.75M | $71.74M | $827.88M | -5.31% |
| 2023-06-30 | $-85.57M | $1.63B | $696.18M | $67.44M | $805.82M | -5.26% |
| 2023-03-31 | $-65.52M | $1.59B | $695.25M | $64.18M | $791.60M | -4.11% |
| 2022-12-31 | $-71.18M | $1.56B | $693.72M | $60.83M | $772.91M | -4.55% |
| 2022-09-30 | $258.24M | $3.98B | $2.30B | (m) | $1.41B | 6.49% |
| 2022-07-01 | $260.05M | $3.96B | $2.29B | (m) | $1.40B | 6.57% |
| 2022-04-01 | $248.45M | $4.00B | $2.33B | (m) | $1.39B | 6.21% |
| 2021-12-31 | $256.64M | $3.85B | $2.24B | (m) | $1.33B | 6.66% |
| 2021-10-01 | $259.68M | $3.66B | $2.11B | (m) | $1.26B | 7.10% |
| 2021-07-02 | $257.62M | $3.50B | $2.01B | (m) | $1.20B | 7.36% |
| 2021-04-02 | $176.76M | $3.13B | $1.82B | (m) | $1.10B | 5.64% |
| 2020-12-31 | $162.29M | $3.07B | $1.78B | (m) | $1.09B | 5.29% |
| 2020-10-02 | $195.73M | $3.13B | $1.80B | (m) | $1.09B | 6.25% |
| 2020-07-03 | $201.66M | $3.17B | $1.82B | (m) | $1.10B | 6.36% |
| 2020-04-03 | $248.12M | $3.46B | $1.97B | (m) | $1.18B | 7.17% |
| 2019-12-31 | $203.61M | $3.33B | $1.93B | (m) | $1.13B | 6.12% |
| 2019-09-27 | $223.90M | $3.74B | $2.90B | (m) | $1.26B | 5.99% |
| 2019-06-28 | $191.10M | $3.73B | $2.77B | (m) | $1.10B | 5.13% |
| 2019-03-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $236.94M | $3.67B | $2.53B | (m) | $818.21M | 6.46% |
| 2018-09-28 | $12.10M | $3.56B | $2.46B | (m) | $798.93M | 0.34% |
| 2018-06-29 | $26.68M | $3.52B | $2.44B | (m) | $785.93M | 0.76% |
| 2018-03-31 | $31.10M | $3.45B | $2.39B | (m) | $758.03M | 0.90% |
| 2018-03-30 | (m) | $3.45B | (m) | (m) | (m) | (m) |
| 2017-12-31 | $29.15M | $3.30B | $2.27B | (m) | $732.34M | 0.88% |
| 2017-09-29 | $265.70M | $3.70B | $2.53B | (m) | $831.82M | 7.18% |
| 2017-06-30 | $274.71M | $3.62B | $2.48B | (m) | $811.57M | 7.58% |
| 2017-03-31 | $255.77M | $3.62B | $2.47B | (m) | $816.90M | 7.07% |
| 2016-12-31 | $238.01M | $3.65B | $2.50B | (m) | $825.24M | 6.53% |
| 2016-09-30 | $237.11M | $3.77B | $2.58B | (m) | $860.28M | 6.28% |
| 2016-07-01 | $232.15M | $3.86B | $2.65B | (m) | $898.03M | 6.01% |
| 2016-04-01 | $255.66M | $3.93B | $2.69B | (m) | $907.11M | 6.50% |
| 2015-12-31 | $284.64M | $3.97B | $2.72B | (m) | $905.95M | 7.18% |
| 2015-09-25 | $326.92M | $4.11B | $2.80B | (m) | $928.23M | 7.95% |
| 2015-06-26 | $400.17M | $4.31B | $2.92B | (m) | $936.42M | 9.29% |
| 2015-03-27 | $399.27M | $4.48B | $3.03B | (m) | $992.82M | 8.91% |
| 2014-12-31 | $409.55M | $4.62B | $3.15B | (m) | $1.01B | 8.86% |
| 2014-09-26 | $421.83M | $4.59B | $3.15B | (m) | $972.41M | 9.19% |
| 2014-06-27 | $405.82M | $4.44B | $3.05B | (m) | $935.73M | 9.14% |
| 2014-03-28 | $421.80M | $4.31B | $2.97B | (m) | $878.39M | 9.78% |
| 2013-12-31 | $406.39M | $4.21B | $2.90B | (m) | $860.99M | 9.66% |
| 2013-09-27 | $338.94M | $4.06B | $2.81B | (m) | $876.10M | 8.34% |
| 2013-06-28 | $287.81M | $4.00B | $2.78B | (m) | $885.11M | 7.19% |
| 2013-03-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $140.01M | $3.91B | $2.76B | (m) | $895.45M | 3.58% |
| 2012-09-28 | $80.27M | $3.06B | $2.13B | (m) | $715.81M | 2.62% |
| 2012-06-29 | $34.04M | $2.28B | $1.57B | (m) | $539.64M | 1.49% |
| 2012-03-30 | $-9.56M | $1.42B | $978.96M | (m) | $335.63M | -0.67% |
| 2012-03-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $25.91M | $693.39M | $453.29M | $5.71M | $144.82M | 3.74% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $34.37M | $541.99M | $350.58M | $6.21M | $119.43M | 6.34% |
| 2010-10-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-02 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $39.63M | $525.02M | $339.24M | $5.93M | $112.50M | 7.55% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |